Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "ORPHAN DRUG" in comments (approximate match)

Showing 1951 - 1960 of 3321 results

First page
Previous page
Next page
Next page

ONFEKAFUSP ALFA

6HXC0O6JMV

Subunit 1 (410) Similarity Search Subunit 2 (410) Similarity Search Subunit 3 (410) Similarity Search

Sequence Search

Subunit 1 (410) Similarity Search Subunit 2 (410) Similarity Search Subunit 3 (410) Similarity Search

Status:

Investigational

Source:

NCT04650984: Phase 3 Interventional Recruiting Soft Tissue Sarcoma

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04650984

Class:

PROTEIN

TAGITANLIMAB

GUY458P83P

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

INN:tagitanlimab [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/GUY458P83P

Class:

PROTEIN

PEPINEMAB

BPZ4A29SYE

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

Investigational

Source:

NCT02481674: Phase 2 Interventional Completed Huntington's Disease

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02481674

Class:

PROTEIN

PEPTIDE YY HUMAN

T2670C12I5

Subunit 1 (36) Similarity Search

Sequence Search

Subunit 1 (36) Similarity Search

Status:

Investigational

Source:

NCT00259233: Not Applicable Interventional Completed Obesity

(2005)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00259233

Class:

PROTEIN

Casdozokitug

AL6I5N2HTN

Subunit 1 (456) Similarity Search Subunit 2 (456) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Sequence Search

Subunit 1 (456) Similarity Search Subunit 2 (456) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Status:

Investigational

Source:

INN:casdozokitug [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/AL6I5N2HTN

Class:

PROTEIN

Ruxoprubart

P9NB0SOG5X

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

INN:13213

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/P9NB0SOG5X

Class:

PROTEIN

GARADACIMAB

32W6AJL0DY

Subunit 1 (456) Similarity Search Subunit 2 (456) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (456) Similarity Search Subunit 2 (456) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT04656418: Phase 3 Interventional Completed Hereditary Angioedema

(2021)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04656418

Class:

PROTEIN

EFPREZIMOD ALFA

FN12T66RMN

Subunit 1 (261) Similarity Search Subunit 2 (261) Similarity Search

Sequence Search

Subunit 1 (261) Similarity Search Subunit 2 (261) Similarity Search

Status:

Investigational

Source:

NCT04317040: Phase 3 Interventional Completed Coronavirus Disease 2019 (COVID-19)

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04317040

Class:

PROTEIN

PENPULIMAB

IBS1BZ4E4I

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT04344158: Phase 3 Interventional Active, not recruiting Advanced Hepatocellular Carcinoma (HCC)

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04344158

Class:

PROTEIN

TEMELIMAB

T32CR1A69R

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (213) Similarity Search

Sequence Search

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (213) Similarity Search

Status:

Investigational

Source:

NCT04480307: Phase 2 Interventional Completed Multiple Sclerosis

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04480307

Class:

PROTEIN

Protein

ONFEKAFUSP ALFA

Protein

Protein

Protein

PEPTIDE YY HUMAN

Protein

Protein

Protein

Protein

EFPREZIMOD ALFA

Protein

Protein

Showing 1951 - 1960 of 3321 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1